StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hansa Biopharma AB (publ)
Stockholm Stock Exchange:HNSA.ST
Sector
Industries
Location
Market Cap
USD 227.97 M
Share Price
USD 2.65
Avg Daily Volume
231,100
Change (1 day)
-0.45%
Change (1 year)
-42.22%
Change (YTD)
-25.11%
Hansa Biopharma AB (publ) EBIT Margin for the year ending December 31, 2024: -391.17%
Hansa Biopharma AB (publ) EBIT Margin is -391.17% for the year ending December 31, 2024, a -27.68% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Hansa Biopharma AB (publ) EBIT Margin for the year ending December 31, 2023 was -540.88%, a 47.59% change year over year.
-
Hansa Biopharma AB (publ) EBIT Margin for the year ending December 31, 2022 was -366.49%, a -77.32% change year over year.
-
Hansa Biopharma AB (publ) EBIT Margin for the year ending December 31, 2021 was -1,615.90%, a -76.57% change year over year.
-
Hansa Biopharma AB (publ) EBIT Margin for the year ending December 31, 2020 was -6,897.93%, a -35.39% change year over year.
Competitors
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Novo Nordisk A/S
USD 67.42
NOVO-B.CO
+0.26
0.39%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
Novartis AG
USD 118.69
NOVN.SW
-0.95
-0.80%
Abbott Laboratories
USD 131.74
ABT
+0.25
0.19%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Thermo Fisher Scientific Inc.
USD 416.31
TMO
-1.68
-0.40%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Boston Scientific Corporation
USD 103.19
BSX
-0.29
-0.28%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Vertex Pharmaceuticals Incorporated
USD 469.55
VRTX
+5.35
1.15%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
CSL Limited
USD 160.99
CSL.AX
-0.54
-0.33%
GSK plc
USD 19.08
GSK.L
+0.31
1.65%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Siemens Healthineers AG
USD 53.67
SHL.DE
+0.10
0.18%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
AbbVie Inc.
USD 190.58
ABBV
+4.19
2.25%
Novo Nordisk A/S
USD 67.42
NOVO-B.CO
+0.26
0.39%
Roche Holding AG
USD 338.90
RO.SW
+1.87
0.56%
Novartis AG
USD 118.69
NOVN.SW
-0.95
-0.80%
Abbott Laboratories
USD 131.74
ABT
+0.25
0.19%
AstraZeneca PLC
USD 140.04
AZN.L
-0.39
-0.28%
Merck & Co., Inc.
USD 82.43
MRK
+0.91
1.12%
Thermo Fisher Scientific Inc.
USD 416.31
TMO
-1.68
-0.40%
Amgen Inc.
USD 299.02
AMGN
+6.51
2.23%
Boston Scientific Corporation
USD 103.19
BSX
-0.29
-0.28%
Pfizer Inc.
USD 24.61
PFE
0.00%
Gilead Sciences, Inc.
USD 109.85
GILD
+0.79
0.72%
Vertex Pharmaceuticals Incorporated
USD 469.55
VRTX
+5.35
1.15%
Sanofi
USD 96.84
SAN.PA
+0.90
0.94%
Bristol-Myers Squibb Company
USD 47.17
BMY
+0.74
1.59%
CSL Limited
USD 160.99
CSL.AX
-0.54
-0.33%
GSK plc
USD 19.08
GSK.L
+0.31
1.65%
Chugai Pharmaceutical Co., Ltd.
USD 46.49
4519.T
+0.50
1.10%
Siemens Healthineers AG
USD 53.67
SHL.DE
+0.10
0.18%
Regeneron Pharmaceuticals, Inc.
USD 547.93
REGN
-0.03
-0.01%